Literature DB >> 10555117

Economic evaluation in the field of cardiology: theory and practice.

B A van Hout1, E S Goes, E W Grijseels, M A van Ufford.   

Abstract

Economic evaluations figure largely in health care. Economic evaluation aims at offering structured information about the balance between costs and effects of a intervention in comparison to another intervention. Four basic types of economic evaluation studies exist: cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis, and cost-benefit analysis. In deciding which types of evaluation should be used in the analysis, the aim of the analysis is determinative. This article illustrates the theory of economic evaluation and concentrates on its use within cardiology. Finally, this article describes the project "Appropriate Medical Care," a project developed by the Royal Dutch Medical Association. In this project results from cost-effectiveness analysis will be taken into consideration in forming guidelines for the treatment of coronary artery diseases.

Entities:  

Mesh:

Year:  1999        PMID: 10555117     DOI: 10.1016/s0033-0620(99)70016-2

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  3 in total

1.  Guidelines for appropriate care: the importance of empirical normative analysis.

Authors:  M Berg; R T Meulen; M van den Burg
Journal:  Health Care Anal       Date:  2001

Review 2.  A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies.

Authors:  Ching-Yun Wei; Ruben G W Quek; Guillermo Villa; Shravanthi R Gandra; Carol A Forbes; Steve Ryder; Nigel Armstrong; Sohan Deshpande; Steven Duffy; Jos Kleijnen; Peter Lindgren
Journal:  Pharmacoeconomics       Date:  2017-03       Impact factor: 4.981

3.  Analysis of research output parameters: density equalizing mapping and citation trend analysis.

Authors:  Beatrix Groneberg-Kloft; Cristian Scutaru; Axel Fischer; Tobias Welte; Carolin Kreiter; David Quarcoo
Journal:  BMC Health Serv Res       Date:  2009-01-27       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.